Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
-
Altimmune to Participate at Two Upcoming Investor Conferences
-
LAVA Reports First Quarter 2025 Financial Results, Provides Business Update
-
Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study
-
Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
-
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025
-
Highland Copper Announces Completion of Copperwood Metallurgical Drilling and Continued Progress on Detailed Engineering
-
Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call
-
Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
-
Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update
-
PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update
-
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences
-
Creative Realities Reports Fiscal 2025 First Quarter Results
-
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
-
Nexxen Reports First Quarter 2025 Financial Results
-
PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!
-
Kornit Digital Reports First Quarter 2025 Results
-
Crown Crafts Announces Quarterly Cash Dividend
-
Coppernico Confirms Large-Scale Copper Skarn System and Expands Pipeline of Priority Targets at Sombrero
-
Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
-
Peter Lambrinakos, O.O.M., CPP, Joins Draganfly’s Public Safety Advisory Board, Strengthening Canadian Leadership in Public Safety
-
Form 8.3 - [Alpha Group International PLC (GB)]
-
New Storage Facilities Under StorageMart and Manhattan Mini Storage Third Party Management in Q1 2025
-
Calian Reports Results for the Second Quarter
-
Net Asset Value(s)
-
Pet Valu Celebrates 40th Anniversary of Dog Guides’ Fundraising Walk
-
Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
-
LeddarTech Announces the Launch of LeddarSim: Next Leap in Realistic Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD) Simulation
-
Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site
-
Payment of dividend
-
Harfang Makes New Gold Discovery and Drills 7.0 g/t Au Over 18.0 m at Sky Lake, Ontario
-
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
-
KP Tissue Releases First Quarter 2025 Financial Results
-
Tower Semiconductor Reports 2025 First Quarter Financial Results
-
Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy
-
Mesa Air Group Reports Fourth Quarter and Fiscal Full-Year 2024 Results
-
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025
-
Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting
-
MADD Canada Releases The Top Ten Report: Municipal Measures to Minimize Impaired Driving and Support Victims and Survivors
-
CanLift Strengthens Rental Fleet Through Strategic Expansion with JLG
-
BioCryst Announces FDA Acceptance of NDA for ORLADEYO® (berotralstat) Oral Granules in Patients with Hereditary Angioedema Aged 2 to 11 Years
-
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability
-
Construction begins on New York’s largest solar energy project
-
Grocery Business Hall of Fame announces 2025 inductees
-
Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations
-
Ocular Therapeutix™ to Participate in Upcoming Investor Conferences
-
Foundation Wealth Partners Announces Expansion in Calgary with Appointment of Matthew Mantle as New Portfolio Manager and Financial Planner
-
Mercury Introduces First Safety-Certifiable, SOSA-aligned Mission Computer for Aviation Platforms
